Salesforce Ventures contributed to an $11.5m round that will fund the addition of more features to Acto's mobile drug information platform.

Cancer and fibrosis therapy developer Forbius has agreed to be acquired by Bristol Myers Squibb nine years after it was spun off by YM BioSciences.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Bill Gates has returned to lead an $85m round for satellite internet provider Kymeta, which has now raised more than $280m since it was set up to advance Duke University research.

Desktop Metal, backed by a large consortium of corporates, will merge with special purpose acquisition company Trine to list on the NYSE at a $2.5bn valuation.

Toronto Innovation Acceleration Partners has scored an exit having invested at least twice in cancer and fibrosis therapy developer Forbius.

Novartis and existing investors GV, Kaiser Permanente Ventures and Roche Venture Fund helped the cancer test developer push its total funding past the $500m mark.

The Teva, Allianz and Takeda-backed telehealth technology producer has filed to raise up to $100m in an offering that will be boosted by another $100m from Google.

Bill Gates has returned to lead an $85m round for satellite internet provider Kymeta, which has now raised more than $280m from investors including Intelsat and Liberty Global.

The Athenahealth-backed telehealth software provider took its total funding to $125m in a round led by HLM Venture Partners.